If your email program has trouble displaying this email, view as a webpage.

The FDA’s Latest Updates on Breast Implant Safety and Effectiveness

The U.S. Food and Drug Administration (FDA) is providing updates on the safety and effectiveness of breast implants.

The updates include information on:

• Medical Device Reports received through June 30, 2024 for:
  • Systemic symptoms in women with breast implants and
  • Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).
• Labeling for approved breast implants, including new breast implants
• Postmarket Safety Information

The FDA is committed to protecting and promoting public health by collecting this information on breast implants and sharing updates.

Questions?

If you have questions about these updates, contact the Division of Industry and Consumer Education.